Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: Analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases-Reference-Cited by-同舟云学术

Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: Analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases

Published:2009-05 Issue:7 Volume:45 Page:1304-1314
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Mylonas Ioannis,Worbs Silvia,Shabani Naim,Kuhn Christina,Kunze Susanne,Schulze Sandra,Dian Darius,Gingelmaier Andrea,Schindlbeck Christian,Brüning Ansgar,Sommer Harald,Jeschke Udo,Friese Klaus

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Theories of endometrial carcinogenesis: a multidisciplinary approach;Sherman;Mod Pathol,2000

2. Endometrial cancer;Amant;Lancet,2005

3. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma;Oreskovic;Gynecol Oncol,2004

4. Chemical and biological characterization of the inhibin family of protein hormones;Vale;Recent Prog Horm Res,1988

5. Regulation and function of inhibins in the normal menstrual cycle;Welt;Semin Reprod Med,2004

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibin subunit beta B (INHBB): an emerging role in tumor progression;Journal of Physiology and Biochemistry;2024-08-26

2. TGF-β signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy;Cancer Pathogenesis and Therapy;2023-12

3. Evolving roles of activins and inhibins in ovarian cancer pathophysiology;American Journal of Physiology-Cell Physiology;2023-02-01

4. An Integrative Bioinformatics Analysis of Microarray Data for Identifying Differentially Expressed Genes in Preeclampsia;Russian Journal of Genetics;2022-07

5. Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management;International Journal of Gynecologic Cancer;2021-01-07